Cecile DE COSTER
Executive Director, Global Regulatory Affairs – Development Strategy, Alexion International
Cecile De Coster has over 16 years of global regulatory strategy experience in rare diseases drug development. She joined Alexion, AstraZeneca Rare Disease, in 2020 to focus on designing and executing regulatory strategies for Alexion’s hematology and nephrology portfolio.
Prior to Alexion, Cécile held numerous regulatory roles at Voisin Consulting Life Sciences, PTC Therapeutics and bluebird bio. Cécile also serves as co-chair of the Avicenna Alliance Pharmaceutical Strategy Task Force, a Center of Expertise for In Silico approaches.